Every so often, I like to look at which ASX All Ords shares have experienced meaningful insider buying.
This is because insider buying is often regarded as a bullish indicator, as few people should know a company and its intrinsic value better than its own directors.
A number of ASX All Ords shares have reported meaningful insider buying this week. Here are a few that caught my eye:
ALS Ltd (ASX: ALQ)
This testing services company's non-executive director, Nigel Garrard, dipped into the market earlier this week. A change of director's interests notice reveals that Garrard picked up 3,150 ALS shares on-market at $12.85 per share on Tuesday. This represents a total consideration of $40,477.50.
Galan Lithium Ltd (ASX: GLN)
This lithium developer's CEO, Juan Pablo Vargas de la Vega, and non-executive director, Terry Gardiner, have been taking advantage of a pullback to load up on shares. Vargas de la Vega bought 249,680 shares for $130,067 and Gardiner bought 200,000 shares for $102,058 through on-market trades.
Healius Ltd (ASX: HLS)
According to a change of director's interests notice, non-executive director Charles Taylor picked up 50,000 Healius shares through an on-market trade this week. Taylor paid $1.4963 per share, which equates to a total consideration of $74,815.
New Hope Corporation Ltd (ASX: NHC)
This coal miner's non-executive director, Jacqueline Elizabeth McGill AO, has added to her holding. On Friday, McGill picked up 10,000 shares through an on-market trade at $4.97 per share. This equates to a total consideration of $49,700 and lifts her holding to 80,000 shares.
PEXA Group Ltd (ASX: PXA)
Finally, this property settlements technology company revealed that independent non-executive director, Melanie Willis, has bought some shares on-market this month. On Friday, Ms Willis snapped up 4,000 shares for approximately $12.53 per share. This represents a total consideration of just over $50,000.
